Hemodialysis, the most commonly employed renal replacement therapy in end‐stage kidney disease, prescriptions have long been standardized as thrice‐weekly at full‐dose; however, HD implementation is not without major complications. Incremental HD modalities are developed to face such one‐size‐fits‐all approach with hop...
Berk Mızrak, Sidar Çopur, F. Casino et al.· Seminars in dialysis· 0 citations
The principal organs involved in the control of mineral homeostasis are the kidneys, parathyroid glands, intestine and bone, which interact in a finely coordinated manner to maintain calcium and phosphorus levels. Mineral balance is disrupted in the context of chronic kidney disease (CKD), triggering compensatory mec...
Juan Miguel Diaz-Tocados, Juan Diego Domínguez-Coral, M. D. de Borst et al.· Clinical Kidney Journal· 0 citations
This review distinguishes aldosterone excess from MR activation and proposes a nephrology-focused clinical framework separating established MRA indications, evaluation for primary aldosteronism, and the unestablished cardiorenal outcome role of aldosterone synthase inhibitors (ASIs).
M. Kanbay, Rama Al-Shiab, Ermeena Shah et al.· Nephrology, Dialysis and Tra...· 0 citations
BACKGROUND AND AIMS
Sodium-glucose cotransporter-2 inhibitors (SGLT2is) improve cardiovascular and kidney outcomes, but their effects on circulating inflammatory biomarkers remain uncertain. We systematically reviewed randomized evidence on the effects of SGLT2is on peripheral-blood inflammatory biomarkers.
METHODS
P...
Mehmet Kanbay, Ermeena Shah, Rama Al-Shiab et al.· Diabetes, obesity and metabo...· 0 citations
Investigating treatments for CKD possess anti-inflammatory properties that might contribute to their previously established clinical benefits, including renin-angiotensin-aldosterone system inhibitors, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocortico...
Katherine R. Tuttle, Mehmet Kanbay, Radica Z. Alicic et al.· Nature Reviews Nephrology· 1 citation
Kidney imaging advances are transforming the field of nephrology by allowing non-invasive examination of renal structure, function, and pathology, and imaging biomarkers show significant predictive value for progression to kidney failure in CKD, including diabetic kidney disease, independent of traditional measurements...
Mustafa Guldan, Ibrahim Gulmaliyev, Rama Al-Shiab et al.· Clinical Kidney Journal· 0 citations
10 tips for non-pharmacological interventions with the potential to modify fracture risk in CKD patients are described, which are often applicable to patients with CKD without restrictions, with some specific considerations in end-stage kidney disease.
D. Hansen, Hanne Skou-Jørgensen, M. Kanbay et al.· Clinical Kidney Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.